Your browser doesn't support javascript.
loading
Activin Type II Receptor Blockade for Treatment of Muscle Depletion in Chronic Obstructive Pulmonary Disease. A Randomized Trial.
Polkey, Michael I; Praestgaard, Jens; Berwick, Amy; Franssen, Frits M E; Singh, Dave; Steiner, Michael C; Casaburi, Richard; Tillmann, Hanns-Christian; Lach-Trifilieff, Estelle; Roubenoff, Ronenn; Rooks, Daniel S.
Afiliação
  • Polkey MI; 1 National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield National Health Service Foundation Trust and Imperial College London, London, United Kingdom.
  • Praestgaard J; 2 Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Berwick A; 3 Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
  • Franssen FME; 4 Department of Research and Education, CIRO, Center of Expertise for Chronic Organ Failure, Horn, the Netherlands.
  • Singh D; 5 Centre for Respiratory Medicine and Allergy, University of Manchester and the Medicines Evaluation Unit, University Hospital of South Manchester National Health Service Foundation Trust, Manchester, United Kingdom.
  • Steiner MC; 6 Centre for Exercise and Rehabilitation Science, National Institute for Health Research Leicester Biomedical Research Centre, Respiratory, Glenfield Hospital, Leicester, United Kingdom.
  • Casaburi R; 7 Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute, Harbor-University of California Los Angeles Medical Center, Torrance, California; and.
  • Tillmann HC; 8 Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Lach-Trifilieff E; 8 Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Roubenoff R; 8 Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Rooks DS; 3 Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
Am J Respir Crit Care Med ; 199(3): 313-320, 2019 02 01.
Article em En | MEDLINE | ID: mdl-30095981

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Composição Corporal / Atrofia Muscular / Anticorpos Bloqueadores / Doença Pulmonar Obstrutiva Crônica / Receptores de Ativinas / Anticorpos Monoclonais Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Composição Corporal / Atrofia Muscular / Anticorpos Bloqueadores / Doença Pulmonar Obstrutiva Crônica / Receptores de Ativinas / Anticorpos Monoclonais Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article